SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Avian ("Bird") Flu Stocks
NNVC 1.660-2.4%Oct 31 9:30 AM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: The Alchemist12/20/2005 2:49:45 PM
   of 428
 
EMFP-

(BSNS WIRE) Emergency Filtration Products Enters into Distribution Agreements
with Nine International Distributors
Emergency Filtration Products Enters into Distribution Agreements with Nine Inte
national Distributors

Business Editors / Health/Medical Writers

HENDERSON, Nev.--(BUSINESS WIRE)--Dec. 20, 2005--
Emergency Filtration Products Inc. (EFP) (OTCBB: EMFP)
today announced that it has entered into distribution agreements with
nine international distributors operating in the following countries:
Australia, Canada, Denmark, New Zealand, Pakistan, South Africa, South
Korea, Sweden and Thailand. The company is also at an advanced stage
of negotiations to sign additional distributors in a number of other
countries.
The international distributors signed to date have agreed to order
a minimum of 550,000 NanoMasks and 7,250,000 NanoMask filters over the
next two years. The current delivery schedule -- which is based on the
company's production capacity -- calls for approximately 225,000
NanoMasks and 3,000,000 NanoMask filters to be delivered in equal
allotments over the course of 2006. In 2007, deliveries to these
distributors are currently scheduled to reach 325,000 NanoMasks and
4,250,000 NanoMask filters. Following the delivery plan for 2006,
deliveries are currently scheduled to be made in equal numbers over
the course of the year. These schedules could be either accelerated
and/or increased should EFP's production capabilities permit and at
the distributors' requests.
"We are well under way to getting our Nogales plant operational in
the near future, a development which has enabled us to sign a number
of distributors in some important international markets," said Douglas
K. Beplate, president and CEO, EFP. "The task before us is to rapidly
ramp up production to meet demand for our NanoMask and NanoMask
filters, which continues to increase. Towards that end, we regard the
Nogales plant to be crucial to the future success of our company. We
intend to not only manufacture NanoMasks and NanoMask filters in
Nogales, but to also manufacture some, if not all of our other
products there as well."
Beplate went on to say, "Our Henderson plant will remain
operational as well, although it may be expanded to accommodate a
fulfillment and distribution center to better serve our customers.
Once our Nogales plant is up and running, we plan to concentrate on
winning new business from some large national and international
companies who have expressed an interest in our products."

About the NanoMask

EFP's 2H Nano-Enhanced Environmental Mask, the NanoMask, relies on
the company's core 2H Technology(TM) filtration system, which utilizes
a combination of hydrophobic and hydrophilic filters able to capture
and isolate bacterial and viral microorganisms with efficiencies of
99.9%. The environmental mask utilizes the company's patented 2H
Technology(TM) and nanotechnology to enhance the capture-and-isolation
characteristics of the filter media.

About Emergency Filtration Products
(http://www.emergencyfiltration.com/)

EFP is an air filtration products manufacturer whose patented 2H
Technology(TM) filter system has produced filtration efficiencies of
"greater than 99.99%" at a particulate size of 0.027 microns. Its
initial products were developed for the medical market: the Vapor
Isolation Valve(TM) and RespAide(R) CPR Isolation Mask used for
resuscitation of respiratory/cardiac arrest cases; and the 2H
Breathing Circuit Filter for ventilators, respirators and anesthesia
circuitry. Each has received FDA approval. The company also markets an
Automated External Defibrillator Prep Kit featuring RespAide; and the
NanoMask(R), a nanotechnology enhanced environmental mask. In addition
to filtration products, the company supplies Superstat(R), a modified
hemostatic collagen, to the U.S. military for surgery and extreme
wound care.

Safe Harbor Statement

This release may contain statements that are forward looking. Such
statements are made based upon current expectations that are subject
to risk and uncertainty. EFP does not undertake to update
forward-looking statements in this news release to reflect actual
results of and changes in assumptions or changes in other factors
affecting such forward-looking information. The actual future results
of the company could differ significantly from such forward-looking
statements. Sales may be dependent on the success of future marketing
campaigns, the signing of definitive agreements with additional
distributors, and both the perceived need for EFP's products and the
competitive performance of such products in the marketplace.

KEYWORD: NORTH AMERICA ARIZONA NEVADA UNITED STATES
INDUSTRY KEYWORD: HEALTH CARDIOLOGY MEDICAL DEVICES CONTRACT/AGREEMENT PRODUCT/S
RVICE
SOURCE: Emergency Filtration Products Inc.

CONTACT INFORMATION:
Emergency Filtration Products Inc., Henderson
Douglas K. Beplate, 702-558-5164
Fax: 702-567-1893
contactus@emergencyfiltration.com
www.emergencyfiltration.com
or
PAN Consultants Ltd. (Investor Relations)
Philippe Niemetz, 800-477-7570, 212-344-6464
Fax: 212-6181276
p.niemetz@panconsultants.com

*** end of story ***
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext